A Pilot Study Of the Effects of Highly Active Antiretroviral Therapy on Kaposi's Sarcoma in Zimbabwe

This study has been completed.
Sponsor:
Collaborators:
University of Colorado, Denver
GlaxoSmithKline
Abbott
Information provided by (Responsible Party):
Margaret Borok, Parirenyatwa Hospital
ClinicalTrials.gov Identifier:
NCT00834457
First received: February 2, 2009
Last updated: October 29, 2014
Last verified: October 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2009
  Primary Completion Date: July 2009 (Final data collection date for primary outcome measure)